Skip to main content
. 2021 May 6;11(5):1325. doi: 10.3390/ani11051325

Table 1.

Primer for quantitative PCR.

Gene Symbol Gene Name NCBI/Ensembl Accession Number Oligo Sequence (5′–3′) Amplicon Length (bp) PCR Efficiency (%) R2 Value Reference
ATP1A1 Equus caballus ATPase Na+/K+ transporting subunit alpha 1 NM_001114532.2, XM_023640223.1, XM_023640224.1 F: CTTGATGAACTTCAGCGCAAATA 104 94 0.990 This study
R: GGTGTAAGGGCATTGGGA
P: TGAGCCGAGGCTTAACAACTGCTC
BAX Equus caballus BCL2-associated X protein XM_014729721.1 F: AGGATGCGTCCACCAAGAAG 80 93.2 0.994 [37]
XM_014729717.1 R: CCTCTGCAGCTCCATGTTACTG
P: CTCAAGCGCATCGGAGATGAGCTG
BCL2 Equus caballus B-cell lymphoma 2 XM_001490436.2 F: TTGGAAAGCCTACCACTAATTGC 74 92.6 0.998 [37]
R: CCGTGTTTATAGGCACAGGAGAT
P: CCCACCTGAGCGGCTCCACC
CYP19A1 Equus caballus cytochrome P450 family 19 subfamily A member 1 NM_001081805.2 F: GGAGAGGAAACGCTCGTTATTA 107 99.2 0.999 This study
XM_005602588.2 R: CCCATATACTGCAACCCAAATG
XM_005602587.2 P: ATCACTACTCCTCCCGATTTGGCA
DNMT1 Equus caballus DNA methyltransferase 1 XM_014741825.1 F: GACCACCATCACGTCTCATTT 97 100.5 1 This study
R: CTCCTCATCCACAGAATTGTCC
P: AAACGGAAACCCGAGGAAGAGCTG
DNMT3A Equus caballus DNA methyltransferase 3 α XM_005600169.2 F: GATTATTGACGAACGCACAAGAG 112 100 0.998 This study
XM_005600168.2
XM_005600167.2
XM_005600170.2 R: GTGTTCCAGGGTGACATTGA
XM_005600171.2 P: TGCAAATGTCTTCGATGTTCCGGC
DNMT3B Equus caballus DNA methyltransferase 3 β XM_001916514.4 F: CGAGTCTTGTCCCTGTTTGAT 110 100.6 0.999 This study
R: GCGATAGACTCTTCACACACTT
P: CGCCACAGGGTACTTGGTTCTCAA
DNMT3L Equus caballus DNA (cytosine-5-)-methyltransferase 3-like XM_014736476.1 F: GCCCTCACTTGGTTGGTTT 98 100.5 0.999 This study
R: CTTCCACACAGGCACAGTTT
P: CAAAGTGCCCATCTGCTCTGGAGA
ESR1 Equus caballus estrogen receptor 1 NM_001081772.1 F: CACCCAGGAAAGCTCCTATTT 110 101.8 0.999 This study
R: CGAGATGACGTAGCCAACAA
P: TCCACCATGCCCTCTACACATTTCC
H19 Equus caballus H19, imprinted maternally expressed transcript NR_027326.2 F: CCTCTAGCTCTGACTCAAGAATATG 103 94.3 0.992 This study
R: CAGGTCCATCTGGTTCCTTTAG
P: ACTCAGGAATCAGCTCTGGAAGGT
IGF1 Equus caballus insulin-like growth factor 1 NM_001082498.2 F: TGCTTCCGGAGCTGTGATCT 67 102 1 [34]
XM_005606471.2
XM_005606472.2
XM_005606470.2 R: CCGACTTGGCAGGCTTGA
XM_005606469.2 P: AGGAGGCTGGAGATGTACTGCGCACC
IGF2 Equus caballus insulin-like growth factor 2 NM_001114539.2 F: AAGTCCGAGAGGGACGTG 100 99.9 0.998 This study
R: ATTGCTTCCAGGCGTTGT
P: CCCGTGGTCAAGCTCTTCCAGT
NANOG Equus caballus Nanog homeobox XM_014740545.1 F: ACAGCCCCGATTCATCCA 72 102.3 0.999 [35]
R: TCTTTGCCTCGCTCGTCTCT
XM_001498808.1 P: CAGTCCCAGAGTAAAACCGCTGCCC
POU5F1 Equus caballus POU class 5 homeobox 1 XM_014734675.1 F: CGGGCACTGCAGGAACAT 73 100.8 0.999 [35]
R: CCGAAAGAGAAAGCGAACTAGTATTG
XM_001490108.5 P: TTCTCCAGGTTGCCTCTCACTCGGTTC
PSMB4 Equus caballus proteasome subunit beta type IV XM_001492317.4 F: CTTGGTGTAGCCTATGAAGCCC 82 93.1 0.991 [38]
XM_005610132.1
XM_008515015.1
XM_005613704.1 R: CCAGAATTTCTCGCAGCAGAG
PTGES2 Equus caballus prostaglandin-endoperoxide synthase 2 NM_001081775.2 F: GAGGTGTATCCGCCCACAGT 81 92.3 0.996 [36]
R: AGCAAACCGCAGGTGCTC
P: TCAGATGGAAATGATCTACCCGCCTCA
SNRPD3 Equus caballus small nuclear ribonucleoprotein D3 polypeptide. XM_001489060.4 F: ACGCACCTATGTTAAAGAGCATG 120 99.4 0.996 [38]
XM_008511652.1 R: CACGTCCCATTCCACGTC
SOX2 Equus caballus SRY box 2 XM_003363345.3 F: TGCGAGCGCTGCACAT 91 99.3 0.998 [35]
R: AGCGTGTACTTATCCTTCTTCATGAG
P: ATAAATACCGTCCTCGGCGGAAAACCAA

R2: correlation coefficient of standard curve; F and R: forward and reverse primer; P: hydrolysis probe.